Specifically designed for the detection of benzodiazepines, the DRI® Benzodiazepine Enzyme Immunoassay offers precise qualitative and semi-quantitative analysis in human urine samples.
Optimized for use in clinical chemistry analyzers, ensuring seamless integration into existing laboratory workflows.
Manufactured by Microgenics, a trusted name in clinical diagnostics, ensuring reliability and accuracy in toxicology testing.
Supports a broad range of benzodiazepine testing needs, from routine screening to detailed toxicological analysis.
Refrigeration required, preserving the integrity and activity of the reagent for reliable results.
